MedTrace Logo

Intravenous Immunoglobulin in Combination Therapy With Antibacterial Agents for SSI of the Lower Digestive Tract

NCT00511212 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2011-07-21

No results posted yet for this study

Summary

The purpose of this study is to assess the clinical usefulness of IVIG in combination therapy with antibacterial agents for severe peritonitis after lower digestive tract surgery.

Conditions

  • Peritonitis
  • Postoperative Complications

Interventions

DRUG

intravenous immunoglobulin

Sponsors & Collaborators

  • Multicenter Clinical Study Group of Osaka, Colorectal Cancer Treatment Group

    lead OTHER

Principal Investigators

  • Morito Monden, MD, PhD · Multicenter Clinical Study Group of Osaka

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
20 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-08-31
Completion
2009-06-30

Countries

  • Japan

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00511212 on ClinicalTrials.gov